Coronary sinus reducer improves symptoms, quality of life for patients with severe CAD
ATLANTA — Use of a coronary sinus reducer improved chest pain symptoms and quality of life for patients with significant coronary artery disease, despite not improving myocardial blood flow, a speaker reported.The results of the randomized, placebo-controlled ORBITA-COSMIC trial were presented at the American College of Cardiology Scientific Session and simultaneously published in The